VasoGenix Pharmaceuticals, Inc. Elects Cleveland Clinic’s James Young, M.D., to its Board of Directors

LENEXA, Kan.--(BUSINESS WIRE)--VasoGenix Pharmaceuticals announced today that heart failure/heart transplant cardiologist James Young, M.D., has been elected to its board of directors. Dr. Young is Chairman of the Division of Medicine at the Cleveland Clinic and a professor in the Department of Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University.
MORE ON THIS TOPIC